Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- Not stated
- Not stated
- Jul 11, 2024
Official announcement on the NIH Guide · opens the funder's page. Always confirm dates there.
Or read the full text here, free with an account. Create free account
Summary
The National Institutes of Health (NIH) hereby notify recipient organizations holding specific types of NIH grants, listed in the full Notice of Funding Opportunity (NOFO), that applications for change of recipient organization status, often referred to in this announcement as Successor-In-Interest, may be submitted to this NOFO…
The full announcement, free with an account
- The full announcement text, not just the first two sentences
On Plus, $39 a month
- The eligibility check against your profile: career stage, institution type, and the windows that close before the deadline does
- Funded precedents: what similar NIH projects received, from the award records in NIH RePORTER
More from National Institutes of Health
NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
$500k